SynAct Pharma AB (STO:SYNACT)
Sweden · Delayed Price · Currency is SEK 20.60
-0.10 (-0.48%)
At close: Feb 10, 2026
SynAct Pharma AB Market Cap
SynAct Pharma AB has a market cap or net worth of 1.1 billion as of February 10, 2026. Its market cap has increased by 111.50% in one year.
Market Cap
1.10B
Enterprise Value
1.03B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
20.60
Market Cap Chart
Since July 11, 2016, SynAct Pharma AB's market cap has increased from 63.75M to 1.10B, an increase of 1,631.61%. That is a compound annual growth rate of 34.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 1.10B | -8.41% |
| Dec 30, 2025 | 1.21B | 189.20% |
| Dec 30, 2024 | 416.76M | 32.69% |
| Dec 29, 2023 | 314.09M | -87.00% |
| Dec 30, 2022 | 2.42B | -34.75% |
| Dec 30, 2021 | 3.70B | 242.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 11, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Flerie AB | 2.77B |
| Diamyd Medical AB | 2.37B |
| Egetis Therapeutics AB | 2.02B |
| BioInvent International AB | 1.73B |
| Genovis AB (publ.) | 1.35B |
| Cantargia AB | 1.26B |
| Xspray Pharma AB | 1.01B |
| Infant Bacterial Therapeutics AB | 770.57M |